Skip to main content

Table 3 Comparison of patients without (AHI < 5/h), with mild (AHI 5–15/h)or moderate to severe (AHI > 15/h) sleep-disordered breathing

From: Sleep-disordered breathing in patients with newly diagnosed lung cancer

 

AHI < 5/h

AHI 5–15/h

AHI > 15/h

p-value

n

51

32

17

N/A

Age, years

66.31 ± 8.48

69.16 ± 8.06

71.35 ± 8.775

0.0736

Male, n (%)

30 (58.8)

24 (75.0)

13 (76.5)

0.2062

BMI, kg/m2

25.53 ± 4.45

26,67 ± 4,95

26.41 ± 4.14

0.5133

AHI, /h

2 [1, 3]

7.7 [5.4, 10.4]

25.2 [18, 45.5]

< 0.0001

ODI, /h

3.1 [1.5, 5.1]

8.5 [4.2, 13.4]

20.6 [9.6, 36.6]

< 0.0001

Mean SpO2, %

91.47 ± 2.56

91.09 ± 2.36

91.35 ± 2.14

0.7900

Time with SpO2 < 90%, min

36 [8, 84]

25.5 [8.3, 92.3]

41 [10.5,63]

0.9999

ESS score

5.74 ± 3.53

6.22 ± 2.72

8.24 ± 3.96

0.0343

PSQI score

6.49 ± 2.69

7.97 ± 3.97

6.71 ± 2.62

0.1137

Snoring, /h

69 [19.6, 148]

61.2 [26.8, 156.4]

69 [30.5,89.7]

0.9343

Histology, n (%)

 SCLC

14 (27.5)

4 (12.5)

5 (29.4)

0.2280

 NSCLC

37 (72.5)

28 (87.5)

12 (70.6)

- Adenocarcinoma

22 (43.1)

18 (56.3)

5 (29.4)

0.7034

- Squamous cell carcinoma

12 (23.5)

7 (21.9)

5 (29.4)

- Other

3 (5.9)

3 (9.4)

2 (11.8)

Tumor stage (UICC), n (%)

 I

3 (5.9)

4 (12.5)

2 (11.8)

0.1556

 II

5 (9.8)

3 (9.4)

5 (29.4)

 III

19 (37.3)

7 (21.9)

2 (11.8)

 IV

24 (47.1)

18 (56.3)

8 (47.1)

Smoking history, n (%)

 Current smoker

27 (52.9)

14 (43.8)

7 (41.2)

0.8782

 Ex-smoker

16 (31.4)

13 (40.6)

7 (41.2)

 Never smoked

8 (15.7)

5 (15.6)

3 (17.6)

Comorbidities, n (%)

 Hypertension

26 (50.1)

21 (65.6)

9 (52.9)

0.4088

 Diabetes

4 (7.8)

6 (18.8)

4 (23.5)

0.1749

 Coronary artery disease

9 (17.6)

7 (21.9)

6 (35.3)

0.3144

 Chronic heart failure

4 (7.8)

3 (9.4)

1 (5.9)

0.9105

 COPD

15 (29.4)

12 (37.5)

2 (11.8)

0.1670

Pulmonary function

 FEV1 (% predicted)

64.69 ± 17.88

67.51 ± 18.65

77.09 ± 20.02

0.0926

 PaO2 (mmHg)

67.62 ± 12.44

66.69 ± 9.01

69.34 ± 17.69

0.9264

  1. Values are mean ± standard deviation, median [first quartile, third quartile], or number of patients (%)
  2. AHI apnea-hypopnea index, BMI body mass index, COPD chronic obstructive pulmonary disease, ESS Epworth Sleepiness Scale, FEV1 Forced Expiratory Volume in 1 s, NSCLC non-small cell lung cancer, ODI oxygen desaturation index, PaO 2 capillary partial pressure of oxygen, PSQI Pittsburgh Sleep Quality Index, SpO 2 oxygen saturation, SCLC small cell lung cancer, UICC Union for International Cancer Control